Pharmacology

Behavioral and systems neuropharmacologist Jerri Rook is recognized by the Alzheimer’s Drug Discovery Foundation with the Goodes Prize to continue her work in Alzheimer’s disease research. Read More

The VBI recently marked its 20th anniversary, a span that has seen the institute’s wide-ranging missions—including administering the university’s Neuroscience Graduate Program, as well as postdoctoral training and community outreach—steadily coalesce under a single umbrella. Read More

Written by Heidi Hall Alpacas aren’t the typical animals that drivers spot as they wind their way through rural Tennessee, but there’s a happy herd of them outside Waverly, where they eat the finest pellets, walk up and down a scenic hill and potentially save lives. They’re owned by… Read More

Sean Davies, Ph.D., associate professor of Pharmacology, was recognized as Pharmacology “Teacher of the Year” during the 25th Annual Joel G. Hardman Student-Invited Pharmacology Forum in Light Hall. Read More

J. David Sweatt, Ph.D., the Evelyn F. McKnight Endowed Chair of the Department of Neurobiology, director of the Civitan International Research Center, and director of the McKnight Brain Institute at the University of Alabama, Birmingham, has been named chair of Vanderbilt’s Department of Pharmacology. Read More

Researchers at Vanderbilt University Medical Center have relieved symptoms in a mouse model of Rett syndrome with a drug-like compound that works like the dimmer switch in an electrical circuit. Read More

Vanderbilt University Medical Center and Ono Pharmaceutical Group, an international company based in Japan, have signed a drug discovery agreement. Read More

From left, Joshua Fessel, M.D., Ph.D., assistant professor of Medicine, Pharmacology and Cancer Biology, receives the 2015 Pharmacology Teaching Award from first-year Pharmacology graduate students Brian Bender, Blake Dieckmann and Stephanie Moore during last week’s 24th annual Joel G. Hardman Student-Invited Pharmacology Forum in Light Hall. (Photo… Read More

The Lustgarten Foundation has awarded a $1.5 million Research Investigator Grant to Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, for research designed to discover new drugs for the treatment of pancreatic cancer. Read More

By shifting evolution into reverse to produce an expensive HIV drug out of a simple sugar, Vanderbilt chemist Brian Bachmann has shown that it may be possible to manufacture exotic and expensive synthetic drugs as easily as brewing beer. Read More

The mechanical forces generated by the rhythmic expansion and contraction of cardiac muscle cells play an active role in the initial stage of heart valve formation. Read More

Get ready to see stars– We’re taking you to space camp. See why mosquitoes bite you more than others Why you should get “Pinterested” in Vanderbilt! All this and more in this week’s VUCast, Vanderbilt’s online newscast. Watch now. [vucastblurb]… Read More

The strength of Vanderbilt biochemistry, especially in the area of metabolism and diabetes, has a lot to do with a brilliant husband-and-wife research team escaping the rise of Nazism in the early 1920s. Read More

  Annick Suzor-Weiner, Counselor for Science and Technology at the Embassy of France, presents the Legion of Honor Medal to Joseph Parello, Ph.D., visiting scholar in the Department of Pharmacology. (Photo by Tommy Lawson) Joseph Parello, Ph.D, visiting scholar in the Department of Pharmacology, received the insignia… Read More

A team led by Vanderbilt University investigators has discovered two new genes — both coding for the signaling protein calmodulin — associated with severe early-onset disorders of heart rhythm. Read More

Vanderbilt University’s Lee Limbird, Ph.D., has received one of pharmacology’s highest honors — the 2013 Julius Axelrod Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET). Read More

Understanding how the main receptor for light interacts with other signaling molecules may inform new pharmaceutical development. Read More

Heidi Hamm, Ph.D., chair of the Department of Pharmacology, has won the 2012 Ariens Award from the Dutch Pharmacological Society. Read More

The spinal cord’s neuropeptide Y signaling pathway may be a good target for new pain therapeutics. Read More

A reversible chemical modification of rhodopsin, a receptor for light, plays a role in the degeneration of retinal cells. Read More